## Gene Summary
FKBP5, formally known as FK506 Binding Protein 5, encodes a member of the immunophilin protein family, which plays a critical role in immunoregulation and basic cellular processes involving protein folding and trafficking. FKBP5 is known for its role in regulating glucocorticoid receptor sensitivity and emotional memory processing. The protein has peptidyl-prolyl isomerase activity, interacting with the glucocorticoid receptor and thus modulating the stress response. FKBP5 is broadly expressed in various tissues but is especially prominent in the brain and immune cells.

## Gene Drugs, Diseases, Phenotypes, and Pathways
FKBP5 has been implicated in several psychiatric disorders, particularly those influenced by stress such as post-traumatic stress disorder (PTSD), depression, and anxiety disorders. It is also associated with conditions like bipolar disorder and schizophrenia. The gene impacts several biological pathways, including the cortisol signaling pathway. Notably, its modulation of glucocorticoid receptor functionality links it to the hypothalamic-pituitary-adrenal (HPA) axis, influencing how the body responds to stress. FKBP5 variations also contribute to differences in inflammation and immune responses.

## Pharmacogenetics
In pharmacogenetics, FKBP5 plays a significant role, particularly concerning the efficacy and metabolism of antidepressants and glucocorticoids. Altered FKBP5 function can affect the pharmacodynamics of these drugs, impacting their therapeutic outcomes. Polymorphisms in FKBP5 have been studied for their impact on the efficacy of antidepressant drugs such as SSRIs (selective serotonin reuptake inhibitors) and their role in the development of side effects. In terms of glucocorticoids used for conditions like asthma and rheumatoid arthritis, FKBP5 genetic variations can modify drug sensitivity and metabolic pathways, thereby influencing treatment responses and potential side effects. Understanding these associations is crucial for tailoring personalized treatment plans and improving therapeutic efficacy.